Potential Association of the ISCHEMIA Trial With the Appropriate Use Criteria Ratings for Percutaneous Coronary Intervention in Stable Ischemic Heart Disease

Ali O Malik; John A Spertus; Manesh R Patel; Gregory J Dehmer; Kevin Kennedy; Paul S Chan

doi:10.1001/jamainternmed.2020.3181

Potential Association of the ISCHEMIA Trial With the Appropriate Use Criteria Ratings for Percutaneous Coronary Intervention in Stable Ischemic Heart Disease

JAMA Intern Med. 2020 Nov 1;180(11):1540-1542. doi: 10.1001/jamainternmed.2020.3181.

Authors

Ali O Malik¹, John A Spertus¹, Manesh R Patel², Gregory J Dehmer³, Kevin Kennedy¹, Paul S Chan¹

Affiliations

¹ St Luke's Mid America Heart Institute, Kansas City, Missouri.
² Duke University, School of Medicine, Durham, North Carolina.
³ Virginia Tech Carilion School of Medicine, Roanoke, Virginia.

Abstract

This cohort study examines the potential implications of the ISCHEMIA trial on the appropriateness of percutaneous coronary intervention in patients with stable ischemic heart disease.

Publication types

Multicenter Study

MeSH terms

Clinical Trials as Topic / methods*
Humans
Myocardial Ischemia / surgery*
Percutaneous Coronary Intervention / methods*
Treatment Outcome

Grants and funding

R01 HL123980/HL/NHLBI NIH HHS/United States